Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan
· Delayed Price · Currency is TWD 27.80
-0.10 (-0.36%)
At close: Apr 29, 2026
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 4.20 billion as of April 29, 2026. Its market cap has decreased by -4.14% in one year.
Market Cap
4.20B
Enterprise Value
2.78B
Revenue
9.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.80
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 4.20B, a decrease of -24.17%. That is a compound annual growth rate of -5.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 4.21B | 5.68% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.90B |
| OBI Pharma | 4.22B |
| ACRO Biomedical | 4.22B |
| Energenesis Biomedical CO.,LTD. | 3.70B |
| Senhwa Biosciences | 4.50B |
| BioGend Therapeutics | 3.61B |
| Medigen Biotechnology | 4.88B |
| Pharmosa Biopharm | 4.91B |